Popular search terms:
Report An Undesirable Effect
Contact information for reporting an Undesirable Effect relating to one of our treatments.
View Contact Information on CSL.comSearch Results
99 results found-
Contact Us | CSL Behring Australia
Our Australian offices are in Melbourne, Victoria, Australia
https://www.cslbehring.com.au/contact-us -
Marketing Statement | CSL Behring Australia
CSL Behring Australia's Marketing Statement
https://www.cslbehring.com.au/marketing-statement -
Privacy | CSL Behring Australia
CSL is committed to protecting the privacy of all the individuals it deals with. This document sets out our policies on handling personal information (including health information).
https://www.cslbehring.com.au/privacy -
Newsroom
Press and News Releases from CSL Behring Australia
https://www.cslbehring.com.au/news/newsroom -
Australian PI . Normal Immunoglobulin-VF
Patients should be informed about first symptoms of thromboembolic events including shortness of breath, pain and swelling of a limb, focal neurological deficits and chest pain and should be advised to contact their physician immediately upon onset of symptoms.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/aus-pis-and-cmis/normal-immunoglobulin-au-pi-1000.pdf -
NEW ZEALAND DATA SHEET 1 PRODUCT NAME Normal Immunoglobulin-VF, 160 mg/mL, solution for injection.
Patients should be informed about first symptoms of thromboembolic events including shortness of breath, pain and swelling of a limb, focal neurological deficits and chest pain and should be advised to contact their physician immediately upon onset of symptoms.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/nz-dss/normal-immunoglobulin-nz-ds-1200.pdf -
CSL Behring Community Grant How To Apply
CSL Behring is a global biotech company leading the way to deliver innovative therapies for rare and serious diseases.
https://www.cslbehring.com.au/our-company/the-csl-behring-commitment/csl-behring-community-grant/how-to-apply -
Partnering with CSL Behring
Our partnering approach is to structure deals that leverage the value of CSL Behring’s world-class R&D, commercial and manufacturing operations.
https://www.cslbehring.com.au/partnering -
Normal IMIG CMI
These The information in this leaflet is contact with a source of include medicines bought subject to change.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/aus-pis-and-cmis/normal-immunoglobulin-au-cmi-1000.pdf